Subscribe
Cardiomyopathy
Treatment of Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, due to unknown causes and often related to genetic factors, is difficult to prevent. It is important to guide patients on how to lead their lives, reminding them to avoid intense physical activities, heavy lifting, or breath-holding to reduce the incidence of sudden death. Avoid using drugs that enhance myocardial contractility and reduce cardiac capacity load, such as digoxin and nitrates, to decrease the aggravation of left ventricular outflow tract obstruction. The treatment principle for this disease is to slow down the hypertrophy of the myocardium, prevent tachycardia, and maintain normal sinus rhythm. It also aims to relieve the narrowing of the left ventricular outflow tract and counteract arrhythmias. Currently, the use of beta blockers and calcium channel blockers is advocated. For severe obstructive patients, interventional and surgical treatments can be carried out, including the implantation of a dual-chamber DTD pacemaker, and the ablation or removal of hypertrophied interventricular septum myocardium.
What department should I register for cardiomyopathy?
Myocardial disease is a common and frequently occurring disease in clinical practice, caused by various reasons leading to pathological changes in the myocardium. Common causes include viral infections, immune system disorders, and other factors, which can lead to degeneration, necrosis, fibrosis, and interstitial edema of the myocardium. This can cause heart failure, arrhythmias, and in severe cases, even death. Therefore, early diagnosis and timely treatment can save patients' lives and alleviate their suffering. It is necessary to consult with a psychiatrist, undergo relevant examinations under the guidance of a psychiatrist, make a clear diagnosis, and actively treat and rescue the patients.
Can myocarditis cause dizziness?
Cardiomyopathy is a fairly common disease in our daily lives. From a medical perspective, cardiomyopathy can usually be divided into dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, and restrictive cardiomyopathy. When cardiomyopathy is present for a long time, it may cause a decline in the heart’s pumping function, leading to a reduction in cardiac output and resulting in heart failure. In such cases, due to insufficient blood supply to the brain, patients often experience symptoms of dizziness. If diagnosed with cardiomyopathy, under the guidance of a doctor, regulated medication can often significantly improve symptoms, including dizziness. (Specific medication usage should be conducted under the guidance of a doctor; do not self-medicate.)
Clinical manifestations of dilated cardiomyopathy
The clinical manifestations of dilated cardiomyopathy can be summarized in two words: "three hearts," which are reflected in the following three aspects. First, heart enlargement, such as through chest X-rays or echocardiography, often reveals a notable enlargement of the patient's heart. Second, arrhythmias; dilated cardiomyopathy often accompanies a variety of arrhythmias, such as frequent ventricular premature beats, tachycardia, or atrial fibrillation. Third, heart failure. Dilated cardiomyopathy often results in symptoms of heart failure, such as exertional dyspnea and paroxysmal nocturnal dyspnea.
How is hypertrophic cardiomyopathy treated?
The treatment of hypertrophic cardiomyopathy aims to improve symptoms, reduce complications, and prevent sudden death. The methods include improving ventricular compliance by reducing outflow tract obstruction, preventing thromboembolic events, and identifying high-risk patients for sudden death. Treatment needs to be individualized, and the main treatments include the following aspects: 1. Medication treatment. Drug treatment is fundamental, and drugs targeting outflow tract obstruction mainly include receptor blockers and non-dihydropyridine calcium channel blockers. For patients with congestive heart failure, targeted treatment is required. Anticoagulation treatment is necessary for patients with atrial fibrillation, and it is worth noting that for patients with chest discomfort, care should be taken to exclude outflow tract obstruction when using nitrate drugs to avoid exacerbation after use. Non-drug treatments include: 1. Surgical treatment: For patients with ineffective drug treatment and heart function class three to four, if there is severe outflow tract obstruction, septal myectomy should be considered. Currently, surgery is listed as the preferred treatment for suitable patients in consensus guidelines in both America and Europe. 2. Alcohol septal ablation; 3. Pacing therapy.
Which department should I register for cardiomyopathy?
Cardiomyopathy is a common disease in our daily lives, characterized primarily by changes in the myocardium. After being diagnosed with cardiomyopathy, many patients often ask which department they should register with at the hospital. Generally speaking, cardiomyopathy falls under cardiovascular diseases, so registration should be with the department of cardiology. Cardiologists often prescribe a cardiac echocardiogram to diagnose myocardial diseases. Conditions such as hypertrophic cardiomyopathy or dilated cardiomyopathy require a cardiac echocardiogram for detection, which is the most commonly used examination for cardiomyopathy.
What should be noted for dilated cardiomyopathy?
Patients with dilated cardiomyopathy should actively look for the cause of the disease and provide corresponding treatments, such as controlling infections, strictly limiting or abstaining from alcohol, treating relevant endocrine or autoimmune diseases, correcting electrolyte disorders, and improving nutritional imbalances, etc. In the early stages of dilated cardiomyopathy, although there is already enlargement of the heart and impairment of contractile function, there are no clinical manifestations of heart failure. At this stage, early pharmacological intervention should be actively implemented to slow down ventricular remodeling and further damage to the myocardium, delaying the progression of the disease. As the condition progresses, the patient's ventricular contractile function further decreases and clinical manifestations of heart failure appear. At this point, treatment should follow the guidelines for chronic heart failure. However, the specifics of the treatment and the choice of medication should be determined by a specialist based on the patient’s condition.